By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic ...
Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...
With highest rate of new HIV cases, Georgia moves to allow pharmacists to prescribe prevention drugs
Lawmakers in Georgia, the state with the highest rate of new HIV infections in the country, are moving to allow pharmacists to prescribe and administer HIV prevention drugs.
Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...
Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...
Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...
GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.
Clinical Trials Arena on MSN
HIV patients show lower steatotic liver disease with ViiV’s Dovato vs Biktarvy
Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results